Bruce Hollis to Hypercalcemia
This is a "connection" page, showing publications Bruce Hollis has written about Hypercalcemia.
Connection Strength
0.345
-
Vitamin D supplementation in multiple sclerosis: making a case for clarity. J Neurol Sci. 2014 Dec 15; 347(1-2):391-2.
Score: 0.114
-
Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D. Am J Med. 2014 Aug; 127(8):772-8.
Score: 0.110
-
Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. J Bone Miner Res. 2005 Oct; 20(10):1792-803.
Score: 0.060
-
Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose. J Clin Endocrinol Metab. 2010 Mar; 95(3):1279-87.
Score: 0.021
-
Alteration in osteoblast activity and nutritional vitamin-D deficiency in non-hypercalcemic malignancy. Calcif Tissue Int. 1988 Jan; 42(1):18-22.
Score: 0.018
-
Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. J Clin Endocrinol Metab. 2003 Apr; 88(4):1603-9.
Score: 0.013
-
Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest. 1999 Jan; 103(2):239-51.
Score: 0.010